Global Human Vaccine Market 2018-2022 | 8% CAGR Projection over the Next Five Years | Technavio
LONDON–(BUSINESS WIRE)–#Biotechnology–The global human vaccine market is expected to post a CAGR of close to 8% during the period 2018-2022,…
Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–#Biotechnology–The global human vaccine market is expected to post a CAGR of close to 8% during the period 2018-2022,…
LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a leading analytics advisory firm, has announced the completion of their new article on the role of big…
KUALA LUMPUR, Malaysia & SINGAPORE–(BUSINESS WIRE)–Eli Lilly (Malaysia) Sdn Bhd Malaysia and Eli Lilly Singapore Pte Ltd, local affiliates of…
ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces…
A significant milestone for the firm’s Canadian investment strategy TORONTO & VANCOUVER, British Columbia & MONTREAL–(BUSINESS WIRE)–Versant Ventures today announced…
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#DigitalDrugDesign–Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases…
Reported positive interim results from clinical trials of AVR-RD-01 investigational gene therapy in Fabry disease, including 87% substrate reduction in…
— Q2 2019 net income of $0.49 per basic and $0.48 per diluted share and adjusted non-GAAP net income of…
Completed multiple financings in 2019, including initial public offering, raising $184.7 million to fund clinical development of novel CNS pipeline…